Bellus Medical, the premier medical aesthetics company, is dedicated to helping leading plastic surgeons, dermatologists, and aesthetic physicians around the world grow their businesses. We do that by delivering dramatic results in rejuvenation and restoration. Our non-invasive innovations – SkinPen®, the first FDA-cleared microneedling device; the post-microneedling protocol Skinfuse®; the light-activated cream Allumera®; and the platelet-rich plasma systems ProGenTM PRP Advantage and ProGenTM PRP Versa – act as “gateway” products that draw new consumers to practices. Based in Dallas, Texas, Bellus sets industry standards for efficacy, safety, and innovation. As a result, our customers consistently deliver the best aesthetic care in the business. Learn more at bellusmedical.com.
• SkinPen®, the first FDA-cleared microneedling device
• The post-microneedling protocol Skinfuse®
• The light-activated cream Allumera®
• The platelet-rich plasma systems ProGenTM PRP Advantage and ProGenTM PRP Versa